The management of epilepsy in clinical practice: Do the timing and severity of the disease influence the priorities of patients and the caring physicians? Data from the EPINEEDS study

被引:4
|
作者
Enia, Gabriele [1 ]
Giussani, Giorgia [1 ]
Bianchi, Elisa [1 ]
Mecarelli, Oriano [2 ]
Beghi, Ettore [1 ]
机构
[1] Ist Ric Farmacolog Mario Negri IRCCS, Lab Malattie Neurolog, Via Mario Negri 2, I-20156 Milan, Italy
[2] Univ La Sapienza, Dipartimento Neurol & Psichiatria Policlin Umbert, UOC Neurofisiopatol & Malattie Muscolari, Milan, Italy
关键词
Epilepsy; Priorities; Needs; Patients; Physicians; QUALITY-OF-LIFE; SEIZURES; CHILDREN; IMPACT;
D O I
10.1016/j.yebeh.2020.107201
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
Objective: The objective of this study was to assess the priorities of patients with epilepsy and their caring physicians with reference to the timing and severity of the disease. Methods: This is a national survey in which patients with epilepsy followed in 21 Italian epilepsy centers, and their caring physicians were asked to fill anonymous questionnaires to collect data on different aspects of the disease and their needs and priorities in its management. The collected information included demographics, clinical profile and diagnosis, treatment and outcome of epilepsy. The questions were designed to understand the expectations of the patients and their caring physicians and verify the degree of concordance between patient and doctor. The study population was divided in six prognostic categories: (1) Newly diagnosed epilepsy; (2) Absence of seizures for at least 2 years; (3) Absence of seizures for at least 1 year or occasional seizures; (4) Nondrug-resistant recurrent seizures; (5) drugresistant seizures; (6) surgical candidate. Results: Of the 787 patients enrolled, 432 were women and 355 men aged 15 to 88 years (median 41 years). Disease duration ranged from 6 months to 75 years. The sample included 53 patients with newly diagnosed epilepsy, 283 without seizures for at least 2 years, 162 seizure-free for at least 1 year or with occasional seizures, 123 with nondrug-resistant recurrent seizures, 128 with drug-resistant seizures, and 38 surgical candidates. Significant differences were found between patients and physicians in terms of priorities and needs with reference to the management of the disease. While physicians tend to prioritize the information on the diagnosis and treatment of epilepsy depending on timing and severity, patients focus on the search of the cause, the side effects of drugs, and the effects of any new treatment on the control of seizures regardless of the prognostic category. In addition, physicians tend to undervalue the communication of specific information, like the risk of sudden unexpected death in epilepsy (SUDEP) or the existence of lay associations, which might be of special interest for selected categories of patients. Significance: Differences between patients with epilepsy and their caring physicians in terms of needs and priorities and suboptimal communication call for the implementation of programs aimed at addressing the factors deemed most relevant by patients and caregivers for the management of the disease. (C) 2020 Elsevier Inc. All rights reserved.
引用
收藏
页数:8
相关论文
共 16 条
  • [1] The management of epilepsy in clinical practice: Do the needs manifested by the patients correspond to the priorities of the caring physicians? Findings from the EPINEEDS Study
    Giussani, Giorgia
    Enia, Gabriele
    Bianchi, Elisa
    Mecarelli, Oriano
    Beghi, Ettore
    Pulitano, Patrizia
    Cagnetti, Claudia
    Baldinelli, Sara
    Lattanzi, Simona
    La Neve, Angela
    Tappata, Maria
    Francavilla, Teresa
    DeMaria, Giovanni
    Sofia, Vito
    Giuliano, Loretta
    Mainieri, Greta
    Fatuzzo, Daniela
    Belcastro, Vincenzo
    Elia, Maurizio
    D'Orsi, Giuseppe
    Lalla, Alessandra
    Salmaggi, Andrea
    Brigo, Francesco
    Magaudda, Adriana
    Pisani, Francesco
    Galletta, Santi
    Pisani, Laura R.
    Raffaele, Massimo
    Cosenza, Domenico
    Villani, Flavio S.
    Quintas, Rui M. M.
    Cervellione, Rosa
    Borroni, Simona
    Meletti, Stefano
    Ferrarese, Carlo
    Barbella, Giuseppina
    Di Francesco, Jacopo
    Bogliun, Graziella
    Beretta, Simone
    Galimberti, Carlo A.
    Cantisani, Teresa A.
    Cecconi, Michela
    Celani, Maria G.
    Papetti, Rossella
    Giorgi, Filippo S.
    Aguglia, Umberto
    Gasparini, Sara
    Ferlazzo, Edoardo
    Manganotti, Paolo
    Crichiutti, Giovanni
    EPILEPSY & BEHAVIOR, 2020, 102
  • [2] Physicians underdiagnose and undertreat obesity in ishemic heart disease patients: Data from the HOLEM study group
    Leibovitz, Eyal
    Gerber, Yariv
    Maislos, Maximo
    Wolfovitz, Efrat
    Chajek-Shaul, Tova
    Leitersdorf, Eran
    Goldbourt, Uri
    Harats, Dror
    ISRAEL MEDICAL ASSOCIATION JOURNAL, 2006, 8 (08): : 553 - 557
  • [3] Effectiveness of eslicarbazepine acetate in 2 different cohorts of patients with epilepsy in clinical practice-Results from a retrospective data collection from 2 epilepsy centers in Germany
    Brandt, C.
    Holtkamp, M.
    May, T. W.
    Pfaefflin, M.
    Mehlig, M.
    Eggert, L.
    Kockelmann, E.
    ZEITSCHRIFT FUR EPILEPTOLOGIE, 2019, 32 (02): : 152 - 159
  • [4] Perampanel in post-stroke epilepsy: Clinical practice data from the PERampanel as Only Concomitant antiseizure medication (PEROC) study
    Pascarella, Angelo
    Manzo, Lucia
    Gasparini, Sara
    Marsico, Oreste
    Abelardo, Domenico
    Torino, Claudia
    Cianci, Vittoria
    Iudice, Alfonso
    Bisulli, Francesca
    Bonanni, Paolo
    Caggia, Emanuele
    D'Aniello, Alfredo
    Di Bonaventura, Carlo
    DiFrancesco, Jacopo C.
    Domina, Elisabetta
    Dono, Fedele
    Gambardella, Antonio
    Fortunato, Francesco
    Marini, Carla
    Marrelli, Alfonso
    Matricardi, Sara
    Morano, Alessandra
    Paladin, Francesco
    Renna, Rosaria
    Piccioli, Marta
    Striano, Pasquale
    Ascoli, Michele
    La Neve, Angela
    Le Piane, Emilio
    Orsini, Alessandro
    Di Gennaro, Gianfranco
    Aguglia, Umberto
    Ferlazzo, Edoardo
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2024, 462
  • [5] Management of patients with malignancies and secondary immunodeficiencies treated with immunoglobulins in clinical practice: Long-term data of the SIGNS study
    Reiser, Marcel
    Borte, Michael
    Huscher, Doerte
    Baumann, Ulrich
    Pittrow, David
    Sommer, Claudia
    Stangel, Martin
    Fasshauer, Maria
    Gold, Ralf
    Hensel, Manfred
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 99 (02) : 169 - 177
  • [6] Eslicarbazepine acetate in epilepsy patients with psychiatric comorbidities and intellectual disability: Clinical practice findings from the Euro-Esli study
    Doherty, Colin P.
    Rheims, Sylvain
    Assenza, Giovanni
    Boero, Giovanni
    Chaves, Joao
    McMurray, Rob
    Villanueva, Vicente
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 402 : 88 - 99
  • [7] Effectiveness and tolerability of lacosamide as add-on therapy in patients with brain tumor-related epilepsy: Results from a prospective, noninterventional study in European clinical practice (VIBES)
    Ruda, Roberta
    Houillier, Caroline
    Maschio, Marta
    Reijneveld, Jaap C.
    Hellot, Scarlett
    De Backer, Marc
    Chan, Jane
    Joeres, Lars
    Leunikava, Iryna
    Glas, Martin
    Grant, Robin
    EPILEPSIA, 2020, 61 (04) : 647 - 656
  • [8] Physicians' predictions of long-term survival and functional outcomes do not influence the decision to admit patients with advanced disease to intensive care: A prospective study
    Escher, Monica
    Nendaz, Mathieu
    Scherer, Fabienne
    Cullati, Stephane
    Perneger, Thomas
    PALLIATIVE MEDICINE, 2021, 35 (01) : 161 - 168
  • [9] Current practice of darbepoetin alfa in the management of haemoglobin levels in cancer patients undergoing chemotherapy -- data from the CHOICE study
    Van Belle, S.
    Karanikiotis, C.
    Labourey, J. -L.
    Galid, A.
    Wheeler, T.
    Pujol, B.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (05) : 987 - 994
  • [10] Treatment with Upadacitinib in Active Psoriatic Arthritis: Efficacy and Safety Data of the First 192 Patients from the UPJOINT Study, a Multicentre, Observational Study in Clinical Practice
    Werner, Stephanie G.
    Baraliakos, Xenofon
    Reckert, Sabine
    Bohl-Buehler, Martin
    Laliberte, Marie-Claude
    Girard, Tanya
    Jeromin, Katharina
    Baschuk, Nikola
    Fritz, Bjorn
    Bessette, Louis
    Hueber, Axel J.
    RHEUMATOLOGY AND THERAPY, 2023, 10 (06) : 1503 - 1518